Abstract
Photodynamic therapy (PDT) is widely used to treat superficial non-melanoma skin cancers and dysplasia. Pain may be experienced during irradiation, with one study showing pain intervention was required in 44% of PDT treatments. Other retrospective studies indicated that large treatment areas on head and neck sites, actinic keratoses and strong protoporphyrin IX fluorescence may be predictors of more severe PDT-induced pain, but data were not conclusive. This article is protected by copyright. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 205-206 |
| Number of pages | 2 |
| Journal | British Journal of Dermatology |
| Volume | 180 |
| Issue number | 1 |
| Early online date | 14 Sept 2018 |
| DOIs | |
| Publication status | Published - Jan 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Dermatology
Fingerprint
Dive into the research topics of 'Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver